M. ERGÜL Et Al. , "Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design," Current Proteomics , vol.19, no.1, pp.83-90, 2022
ERGÜL, M. Et Al. 2022. Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design. Current Proteomics , vol.19, no.1 , 83-90.
ERGÜL, M., AKTAN, F., & TUTAR, Y., (2022). Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design. Current Proteomics , vol.19, no.1, 83-90.
ERGÜL, MUSTAFA, FÜGEN AKTAN, And YUSUF TUTAR. "Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design," Current Proteomics , vol.19, no.1, 83-90, 2022
ERGÜL, MUSTAFA Et Al. "Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design." Current Proteomics , vol.19, no.1, pp.83-90, 2022
ERGÜL, M. AKTAN, F. And TUTAR, Y. (2022) . "Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design." Current Proteomics , vol.19, no.1, pp.83-90.
@article{article, author={MUSTAFA ERGÜL Et Al. }, title={Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design}, journal={Current Proteomics}, year=2022, pages={83-90} }